Results Study population We identified 73,895 new users of GLP-1 receptor agonists and 113,207 new users of SGLT2 inhibitors (Table 1)
A novel cardiometabolic therapeutic prospect Cardiometabolic diseases as diabetes mellitus, heart disease, overweight, obesity, hypertension, hyperlipidemia and its multiple macro and microvascular complications (ischemic cardiomyopathy, stroke, chronic kidney disease, retinopathy, peripheral neuropathy, etc.) are conditions closely related to each other and constitute at present time the leading cause of morbility, disability and death in the world [28]

In biochemistry, L-carnitine: Facilitates the transport of activated long-chain fatty acids across the inner mitochondrial membrane Helps regulate the ratio of acyl-CoA to free CoA in mitochondria Participates in removing toxic compounds from mitochondria Is involved in branched-chain amino acid metabolism Peptide Information L-Carnitine Structure Source: PubChem L-Carnitine Research L-Carnitine is a versatile compound with therapeutic potential across various health domains, including cardiovascular health, metabolic disorders, neurological conditions, exercise recovery, and male fertility
Chromium Picolinate Chromium is an essential trace mineral involved in carbohydrate and fat metabolism
The Cleveland Clinics long-term data showed: Over 10 years, surgical patients lost on average 21.6% of their TBW versus only 6.8 % lost by GLP-1 users
Like any other medicine, retatrutide can cause some side effects